Ameliorative effect of vitamin C on hexavalent chromium-induced delay in sexual maturation and oxidative stress in developing Wistar rat ovary and uterus.
Hexavalent chromium (CrVI) is a highly toxic metal and major environmental pollutant and is extensively used in more than 50 industries. The major route of CrVI exposure for the general population is oral intake. Chromium is considered an important nutrient responsible for carbohydrate metabolism. However, excess CrVI exposure is associated with various pathological conditions including reproductive dysfunction. CrVI can traverse the placental barrier and cause wide range of abnormalities in fetal development. Cr is transported to offspring through mother's milk in lactating women exposed to CrVI. Therefore, the present study was carried out to determine the toxic effects of lactational CrVI exposure on ovary and uterus and the beneficial role of vitamin C in preventing/ameliorating the toxic effects of CrVI in developing female Wistar rats. Generation of oxidative stress is considered one of the plausible mechanisms behind Cr-induced cellular deteriorations. The present study evidenced a decrease in the specific activities of antioxidants, serum testosterone and progesterone and an increase in the levels of H₂O₂, lipid peroxidation (LPO) and follicle stimulating hormone in rats exposed to CrVI when compared to control. CrVI exposure also delayed the sexual maturation and extended the estrous cycle. Simultaneous administration of vitamin C significantly prevented the increase in LPO and enhanced the antioxidant status. These results suggest the protective effect of vitamin C against the CrVI exposure-induced toxicity and attest the significance of antioxidants in diet.
Department of Zoology, St. John's College, Thirunelveli, Tamil Nadu, India. drbjsamuel@yahoo.co.in
Jawahar B
JB
Samuel
Jone A
JA
Stanley
Ganapathy
G
Vengatesh
Rajendran A
RA
Princess
Sridhar
S
Muthusami
Dailiah P
DP
Roopha
Esakky
E
Suthagar
Kathiresh M
KM
Kumar
Maria S
MS
Sebastian
Michael M
MM
Aruldhas
D000818:Animals; D000975:Antioxidants / Q000494:pharmacology; D001205:Ascorbic Acid / Q000494:pharmacology*; D001835:Body Weight; D002857:Chromium / Q000032:analysis / Q000097:blood / Q000633:toxicity*; D030762:Estrous Cycle; D005260:Female; D005640:Follicle Stimulating Hormone / Q000097:blood; D006861:Hydrogen Peroxide; D007774:Lactation; D015227:Lipid Peroxidation / Q000187:drug effects; D007986:Luteinizing Hormone / Q000097:blood; D018811:Maternal Exposure; D009929:Organ Size; D010053:Ovary / Q000737:chemistry / Q000187:drug effects* / Q000254:growth & development / Q000378:metabolism; D018384:Oxidative Stress / Q000187:drug effects*; D010088:Oxidoreductases / Q000378:metabolism; D011247:Pregnancy; D051381:Rats; D017208:Rats, Wistar; D012741:Sexual Maturation / Q000187:drug effects*; D014599:Uterus / Q000737:chemistry / Q000187:drug effects* / Q000254:growth & development / Q000378:metabolism
D000975:Antioxidants; D002857:Chromium; C074702:chromium hexavalent ion; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone; D006861:Hydrogen Peroxide; D010088:Oxidoreductases; D001205:Ascorbic Acid